Assignee
MONTELINO THERAPEUTICS INC
US·4 granted patents·8 pending applications·5 citations·filing 2020–2023
Top patents by PatentIndex Score
12 records- 0186US11098025B2Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2020·Granted Aug 24, 2021·3 cites·20 claims
- 0282US11787778B2Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·1 cites·19 claims
- 0377US11547759B2Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2020·Granted Jan 10, 2023·1 cites·19 claims
- 0473US2024002360A1Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0565US2023241227A1Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0653US11981672B2Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·0 cites·19 claims
- 0753US2024207415A1Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0852US2023132823A1Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0950US2024317734A1Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1050US2024408106A1Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1150US2024376118A1Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1249US2024382603A1Bi-functional compounds and methods for targeted ubiquitination of androgen receptorMONTELINO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MONTELINO THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →